W M Kast - JoVE Visualize

Showing results (21-30 of 128) with videos related to

Pageof 13

Sort By:

Journal of Immunology (Baltimore, Md. : 1950)|April 21, 2001

Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cellsD I Gabrilovich, M P Velders, E M Sotomayor, et al.

Molecular Immunology|December 1, 1994

Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicityM C Feltkamp, M P Vierboom, W M Kast, et al.

The Journal of Experimental Medicine|September 1, 1986

Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC-restricted and MHC-regulated; a model for MHC-disease associationsW M Kast, A M Bronkhorst, L P de Waal, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001

Human T-cell responses to HLA-A-restricted high binding affinity peptides of human papillomavirus type 18 proteins E6 and E7M P Rudolf, S Man, C J Melief, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2001

Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitroM P Rudolf, S C Fausch, D M Da Silva, et al.

Virology|March 9, 2002

Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccinesD M Da Silva, D V Pastrana, J T Schiller, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996

Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumorsR E Toes, R J Blom, R Offringa, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 23, 1996

Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance inductionR E Toes, R Offringa, R J Blom, et al.

Cancer Research|July 17, 2001

Tetra-O-methyl nordihydroguaiaretic acid induces G2 arrest in mammalian cells and exhibits tumoricidal activity in vivoJ D Heller, J Kuo, T C Wu, et al.

Cancer Research|August 2, 2001

Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate miceD Yang, G E Holt, M P Velders, et al.

Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:

Pageof 13

Journal of Immunology (Baltimore, Md. : 1950)|April 21, 2001

Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cellsD I Gabrilovich, M P Velders, E M Sotomayor, et al.

Molecular Immunology|December 1, 1994

Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicityM C Feltkamp, M P Vierboom, W M Kast, et al.

The Journal of Experimental Medicine|September 1, 1986

Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC-restricted and MHC-regulated; a model for MHC-disease associationsW M Kast, A M Bronkhorst, L P de Waal, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001

Human T-cell responses to HLA-A-restricted high binding affinity peptides of human papillomavirus type 18 proteins E6 and E7M P Rudolf, S Man, C J Melief, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2001

Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitroM P Rudolf, S C Fausch, D M Da Silva, et al.

Virology|March 9, 2002

Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccinesD M Da Silva, D V Pastrana, J T Schiller, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996

Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumorsR E Toes, R J Blom, R Offringa, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 23, 1996

Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance inductionR E Toes, R Offringa, R J Blom, et al.

Cancer Research|July 17, 2001

Tetra-O-methyl nordihydroguaiaretic acid induces G2 arrest in mammalian cells and exhibits tumoricidal activity in vivoJ D Heller, J Kuo, T C Wu, et al.

Cancer Research|August 2, 2001

Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate miceD Yang, G E Holt, M P Velders, et al.

Pageof 13